Antti Vaheri
- Immunology and Allergy top 0.02%
- Cell Adhesion Molecules Research 95
- Infectious Diseases top 0.02%
- Viral Infections and Vectors 245
- Viral Infections and Outbreaks Research 122
- Cancer Research top 0.1%
- Protease and Inhibitor Mechanisms 85
- Global and Planetary Change top 0.2%
- Fire effects on ecosystems 121
- Cell Biology top 0.1%
-
- Vector-Borne Animal Diseases 56
-
- Mosquito-borne diseases and control 54
-
- Virology and Viral Diseases 44
- Co-authors
- Olli VapalahtiErkki RuoslahtiAlexander PlyusninKari AlitaloJukka MustonenS StenmanJorma WartiovaaraHeikki Henttonen
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Antti Vaheri
654 papers receiving 31.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Immunology and Allergy 6.4k
- Infectious Diseases 11.4k
- Cancer Research 5.1k
- Global and Planetary Change 5.4k
- Cell Biology 3.9k
Countries citing papers authored by Antti Vaheri
This map shows the geographic impact of Antti Vaheri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antti Vaheri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antti Vaheri more than expected).
Fields of papers citing papers by Antti Vaheri
This network shows the impact of papers produced by Antti Vaheri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antti Vaheri. The network helps show where Antti Vaheri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antti Vaheri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 6 | |
| 9 | 2019 | 5 | |
| 10 | 2011 | 45 | |
| 11 | 2008 | 81 | |
| 12 | Niveles elevados del inhibidor 1 del activador del plasminógeno en los pulmones de niños pretérmino con síndrome de distrés respiratorio | 2006 | 1 |
| 13 | 2005 | 50 | |
| 14 | 2003 | 77 | |
| 15 | Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. | 2001 | 97 |
| 16 | Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy. | 2000 | 89 |
| 17 | Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. | 1996 | 71 |
| 18 | Rapid appearance of plasmin in tear fluid after ocular allergen exposure. | 1988 | 21 |
| 19 | 1984 | 21 | |
| 20 | Fibroblast surface protein. | 1978 | 15 |
About Antti Vaheri
Antti Vaheri is a scholar working on Immunology and Allergy, Infectious Diseases and Cancer Research, having authored 655 papers that have together received 33.4k indexed citations. Recurring topics across this work include Viral Infections and Vectors (245 papers), Viral Infections and Outbreaks Research (122 papers), Fire effects on ecosystems (121 papers), Cell Adhesion Molecules Research (95 papers), Protease and Inhibitor Mechanisms (85 papers), Vector-Borne Animal Diseases (56 papers), Mosquito-borne diseases and control (54 papers) and Virology and Viral Diseases (44 papers). The work is most often cited by research in Immunology and Allergy (6.4k citations), Infectious Diseases (11.4k citations) and Cancer Research (5.1k citations). Antti Vaheri has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Olli Vapalahti, Erkki Ruoslahti, Alexander Plyusnin, Kari Alitalo, Jukka Mustonen, S Stenman, Jorma Wartiovaara, Heikki Henttonen, Åke Lundkvist and Klaus Hedman. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.